1. Home
  2. POWL vs NUVL Comparison

POWL vs NUVL Comparison

Compare POWL & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

HOLD

Current Price

$185.89

Market Cap

6.6B

Sector

Energy

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$103.39

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWL
NUVL
Founded
1947
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
7.8B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
POWL
NUVL
Price
$185.89
$103.39
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$427.00
$134.13
AVG Volume (30 Days)
188.8K
541.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
0.20%
N/A
EPS Growth
20.91
N/A
EPS
3.40
N/A
Revenue
$448,716,000.00
N/A
Revenue This Year
$11.56
N/A
Revenue Next Year
$8.77
$1,165.56
P/E Ratio
$161.12
N/A
Revenue Growth
13.34
N/A
52 Week Low
$154.50
$55.54
52 Week High
$612.50
$113.02

Technical Indicators

Market Signals
Indicator
POWL
NUVL
Relative Strength Index (RSI) 22.24 56.58
Support Level N/A $101.37
Resistance Level $279.77 $107.13
Average True Range (ATR) 30.71 3.52
MACD -22.31 1.02
Stochastic Oscillator 2.15 71.98

Price Performance

Historical Comparison
POWL
NUVL

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: